All News
Filter News
Found 808,690 articles
-
Ex Renaissance Rx CEO Files Suit Alleging Founder Broke Partnership Promises
1/19/2015
-
Becton, Dickinson and Company Grabs Partial Win in $352 Million Anti-Trust Loss to Retractable Technologies, Inc.
1/19/2015
-
NYPD Chief Dies From Blood Cancer Linked To Ground Zero
1/19/2015
-
Depomed, Inc. Smacks Down $1.05 Billion for Johnson & Johnson's Pain Drug Franchise
1/19/2015
-
Johnson & Johnson Lands $115 Million to Speed Up Development of Ebola Vaccine
1/19/2015
-
Pfizer Plots Path Outside of Melanoma in Bid to Join Cancer Race
1/19/2015
-
Steer Clear Of These 5 Internal Hiring Pitfalls
1/19/2015
-
People Start Drinking For Health Benefits: Should We Believe It? Alcoholism: Clinical and Experimental Reveals
1/19/2015
-
Boehringer Ingelheim Corporation Release: OFEV® (Nintedanib*) Approved In The EU For The Treatment Of IPF
1/19/2015
-
Invion Limited Shows Off Positive Phase 2 Data for Smokers Trying to Quit
1/19/2015
-
Fresenius Kabi AG Receives FDA Approval For Neostigmine Methylsulfate Injection
1/19/2015
-
Flowonix Announces FDA PMA(S) Approval Of Prometra II
1/19/2015
-
Biotech IPOs Up 22% Since "Bubble" Year of 2000, Shows New Data
1/19/2015
-
FDA Grants Priority Review For Three-Month Paliperidone Palmitate For The Treatment Of Schizophrenia
1/19/2015
-
Marathon Pharmaceuticals, LLC Receives FDA Fast Track Designation For Deflazacort As A Potential Treatment For Duchenne Muscular Dystrophy
1/19/2015
-
PharmaEngine, Inc. Announces Expanded Analyses Of Phase 3 MM-398 NAPOLI-1 Study Presented At The 2015 American Society of Clinical Oncology GI Substantiate The Positive Results Of MM-398 In Combination With 5-FU/LV
1/19/2015
-
Century-Old Drug Reverses Autism-Like Symptoms, University of California, San Diego (UCSD) Study
1/19/2015
-
Could Our Brain Instruct Our Bodies To Burn More Fat? Monash University Study
1/19/2015
-
Bone Therapeutics Demonstrates Efficacy In First Patient Cohort In ALLOB® Phase I/IIA Delayed-Union Trial
1/19/2015
-
Neurocrine Biosciences, Inc. Announces Granting Of Orphan Drug Status For NBI-77860 In Congenital Adrenal Hyperplasia
1/19/2015